Journals / Kocatepe Veteriner Dergisi / 2021 / Cilt: 14 - Sayı: 4

Hepatoprotective Effect of Pomegranate (Punica Granatum L.) in A Rabbit Model of Steatohepatitis

Bir Tavşan Steatohepatit Modelinde Narın (Punica Granatum L.) Hepatoprotektif Etkisi

Pages
507–519
Publication Date
2021-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results showed that the serum albumin concentration was significantly different in the LPJE group (100 mg/kg) than in the positive control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The study aimed to exhibit liver protection, activity, and probable side effects of LPJE on a steatohepatitis rabbit model.
📊
Key Findings & Data:In this study, 48 rabbits were used.
💡
Conclusion & Impact:Results showed that the serum albumin concentration was significantly different in the LPJE group (100 mg/kg) than in the positive control group.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Punica granatum · antioksidan aktivite · biyoaktivite

Abstract

The study aimed to exhibit liver protection, activity, and probable side effects of LPJE on a steatohepatitis rabbit model. In this study, 48 rabbits were used. The first group (Group 1) rabbits were fed a standard diet (SD), while the second group (Group 2) rabbits were fed a high-fat diet (HFD). In two groups, three different doses of LPJE (25 mg/kg, 50 mg/kg, and 100 mg/kg) were given simultaneously to the rabbits for eight weeks. Results showed that the serum albumin concentration was significantly different in the LPJE group (100 mg/kg) than in the positive control group. The cholesterol concentration of the LPJE (50mg/kg) administered subgroup of Group 2 (96.71 ± 12.03) was found to be the lowest. According to histopathological examination results, Group 2 did not display a statistical difference; however, the lowest liver fat deposition degree was 26.49 ± 8.64% in the LPJE (50 mg/kg) subgroup. As a result of this study, the lyophilized pomegranate extract has hepatoprotective activity. The most effective dose was 50 mg/kg on the non-alcoholic steatohepatitis (NASH) rabbit model. No side effects were determined up to 100 mg/kg pomegranate juice extract on rabbits.

Özet

Bu çalışmada, bir steatohepatit tavşan modelinde Liyofilize nar suyu ekstresinin (LPJE) karaciğer koruması, aktivitesi ve olası yan etkilerinin gösterilmesi amaçlandı ve 48 tavşan kullanıldı. Birinci grup (Grup 1) tavşanlara standart bir diyet (SD), ikinci grup (Grup 2) tavşanlara ise yüksek yağlı bir diyet (HFD) verildi. Her iki gruptaki üçer alt grup tavşanlara sekiz hafta boyunca eş zamanlı olarak üç farklı dozda LPJE (25 mg/kg, 50 mg/kg ve 100 mg/kg) verildi. Pozitif ve standart kontrol grubu tavşanlara ise 1 ml cmc solüsyonu içirildi. Sonuçlar; serum albümin konsantrasyonunun LPJE grubunda (100 mg/kg) pozitif kontrol grubundan önemli ölçüde farklı olduğunu gösterdi. En düşük kolesterol konsantrasyonu, Grup 2'nin (96.71 ± 12.03) LPJE (50mg/kg) uygulanan alt grubunda bulundu. Histopatolojik inceleme sonuçlarına göre Grup 2 istatistiksel olarak farklılık göstermedi; ancak en düşük karaciğer yağlanma derecesi LPJE (50 mg/kg) alt grubunda %26.49 ± 8.64 olarak ölçüldü. Sonuç olarak, liyofilize nar ekstresinin hepatoprotektif aktivite gösterdiği ve alkolsüz steatohepatit (NASH) tavşan modelinde en etkili dozun 50 mg/kg olduğu saptandı. Ayrıca tavşanlarda 100 mg/kg nar suyu ekstresine kadar herhangi bir yan etki tespit edilmedi.

🔖

Cite This Article

BAŞER, D. F., AKKOL, E. K., BOZKURT, M., SÜNTAR, İ., CİVELEK, T. (2021). Hepatoprotective Effect of Pomegranate (Punica Granatum L.) in A Rabbit Model of Steatohepatitis. Kocatepe Veteriner Dergisi, Cilt: 14 - Sayı: 4, 507–519. https://ajindex.com/articles/397598

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Adorini L, Pruzanski M, Shapiro D. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discovery Today. 2012; 17(17-18):988-997.
  2. Afaq F, Saleem M, Krueger CG, Reed JD, Mukhtar H. Anthocyanin and hydrolysable tannin-rich pomegranate fruit extract modulates MAPK and NF-ĸB pathways and inhibits skin tumorigenesis in CD-1 mice. International Journal of Cancer. 2005; 113(3):423-433.
  3. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999; 30(6):1356-1362.
  4. Ashoush IS, El-Batawy OI, El-Shourbagy GA. Antioxidant activity and hepatoprotective effect of pomegranate peel and whey powders in rats. Annals of Agricultural Sciences. 2013; 58(1):27-32.
  5. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications of LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. The American Journal of Clinical Nutrition. 2000; 71(5):1062–1076.
  6. Bayan K, Danış R, Altıntas A, Keklikçi SU. Nonalkolik Hepatosteatozun Biyokimyasal Özellikleri. Dicle Tıp Dergisi. 2004; 31(1):23-26.
  7. Besson-Bard A, Pugin A, Wendehenne D. New insights into nicric oxide signaling in plants. Annual Review of Plant Biology. 2008; 59:21-39. Brunt EM. Pathology of steatohepatitis. Best Practice & Research Clinical Gastroenterology. 2002; 16(5):691-707.
  8. Celik I, Temur A, Isik I. Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flower infusion against trichlorocetic acid-exposed in rats. Food and Chemical Toxicology. 2009; 47(1):145-149.
  9. Civelek T, Aydin I, Cingi CC, Yilmaz O, Kabu M. Serum Non-Esterified Fatty Acids and Beta-Hydroxybutyrate in Dairy Cows with Retained Placenta. Pakistan Veterinary Journal. 2011; 31(4):341-344.
  10. Çolak Y, Tuncer İ. Nonalkolik karaciğer yağlanması ve steatohepatit. İstanbul Tıp Fakültesi Dergisi. 2010; 73(3):85-88.
  11. El-Nemr SE, Ismail IA, Ragab M. Chemical composition of juice and seeds of pomegranate fruit. Food/Nahrung. 1990; 34(7):601-606.
  12. Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia. International Journal for Vitamin and Nutrition Research. 2006; 76(3):147-51.
  13. Faria A, Monteiro R, Mateus N, Azevedo I, Calhau C. Effect of pomegranate (P